Detecting Prokaryote-Specific Gene and Other Bacterial Signatures in Thrombi from Patients with Acute Ischemic Stroke

doi:10.21203/rs.3.rs-3218709/v1

Download PDF

Research Article

Detecting Prokaryote-Specific Gene and Other Bacterial Signatures in Thrombi from Patients with Acute Ischemic Stroke

https://doi.org/10.21203/rs.3.rs-3218709/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 23 Jan, 2024

Read the published version in Thrombosis Journal →

You are reading this latest preprint version

Background and Purpose—Microbial infection has been associated with thrombogenesis. This study aimed to detect bacterium-specific genes and other signatures in thrombi from patients with acute ischemic stroke and to relate these signatures to clinical characteristics.

Methods—Blood samples were collected before thrombectomy procedures, and thrombus samples were obtained during the procedure. Identification and classification of bacteria in the samples were accomplished using 16S rRNA gene sequencing. Bacterium-specific structures were observed with transmission electron microscopy. Bacterium-specific biomarkers were detected through immunohistochemical staining.

Results—16S rRNA gene was detected in 32.1% of the thrombus samples from 81 patients. Bacillus(0.04% vs 0.00046%, p =0.003), Parabacteroides (0.20% vs 0.09%, p =0.029), Prevotella (1.57% vs 0.38%, p =0.010), Streptococcus (1.53% vs 0.29%, p =0.001), Romboutsia (0.18% vs 0.0070%, p =0.029), Corynebacterium (1.61% vs 1.26%, p =0.026) and Roseburia (0.53% vs 0.05%, p =0.005) exhibited significantly higher abundance in thrombi compared to arterial blood. Bacteria-like structures were observed in 22 (27.1%), while whole bacteria-like structures were observed in 7 (8.6%) thrombi under transmission electron microscopy. Immunohistochemical staining detected bacterium-specific monocyte/macrophage markers in 51 (63.0%) out of 81 thrombi. Logistic regression analysis indicated that alcohol consumption was associated with a higher bacteria burden in thrombi (odds ratio =3.19; 95% CI, 1.10-9.27; p =0.033).

Conclusion—Bacterial signatures usually found in the oral cavity and digestive tract were detected in thrombi from patients with ischemic stroke. This suggests a potential involvement of bacterial infection in the development of thrombosis. Long-term alcohol consumption may potentially enhance this possibility.

Bacteria

Thrombus

Ischemic stroke

DNA

Endovascular treatment

Bacterial infections have been associated with thrombotic events directly or indirectly (1). Elevated levels of serum antibodies against Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Helicobacter pylori have been linked to an increased risk of stroke (2). Gut microbial ligands could potentially promote atherogenesis and thrombogenesis by activating toll-like receptors (3, 4). Periodontitis and tooth loss, which are usually caused by oral microbiota dysbiosis (5), have been associated with a higher risk of stroke (6). Exposure to multiple microorganisms, known as infectious burden, may result in greater cardiovascular risks compared to exposure to a single microorganism (7).

Recent studies have shown various bacteria within atherosclerotic plaques and thrombi, indicating their potential involvement in related conditions. The use of 16S ribosomal DNA (rDNA) analysis has allowed for the detection of microbial signatures from both oral and gut microbiota within atherosclerotic plaques (8, 9). Oral bacteria have also been detected within thrombi obtained from patients with acute myocardial infarction and peripheral vascular disease (10–12). Periodontal bacteria, including Streptococcus mutans, Prevotella intermedia, and Porphyromonas gingivalis, have been found in the valvular tissue of patients with cardiovascular diseases (13).

The scarcity of available biological samples has limited the investigation of bacterial signatures in cerebral artery thrombus. Recent technical progress and accumulating evidence have facilitated the clinical application of endovascular thrombectomy for the treatment of acute ischemic stroke. This procedure has allowed for the retrieval of a significant number of cerebral artery thrombi, making it technically feasible to conduct component analysis on these thrombi. In light of these developments, this study aimed to investigate the microbial community signatures and assess the diversity of bacteria within thrombi obtained from patients with acute ischemic stroke.

Patients

During the period from January 1, 2018, and October 31, stroke patients who underwent endovascular recanalization treatment were recruited from Jinling Hospital for this study. The Ethic Review Board of Jinling Hospital approved the study protocol, and all participants provided informed consent before enrollment.

The inclusion criteria for the study involved patients who were diagnosed with acute ischemic stroke and underwent mechanical endovascular thrombectomy. Patients were excluded if they had a known diagnosis of bacteremia or septicemia at the time of enrollment or if no thrombus was successfully retrieved during the endovascular procedure.

Stroke Evaluation and Endovascular Treatment

The severity of stroke in the enrolled patients was assessed using the National Institutes of Health Stroke Scale (NIHSS). Subtypes of ischemic stroke were determined according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria (14). Successful reperfusion following the endovascular thrombectomy procedure was defined as a modified Thrombolysis in Cerebral Infarction Score (mTICI) of 2b/3 (15).

Detection of Bacterial Signatures

Each thrombus was promptly divided into 3 segments after being retrieved. One segment was placed in a pyrogen-free Eppendorf tube for nucleic acid sequencing. Another segment was fixed in 4% paraformaldehyde for immunohistochemical examination, and the third one was fixed in 2.5% glutaraldehyde for electron microscopic scanning. Arterial blood and venous blood samples were obtained from the patients before the endovascular procedure, and stored in pyrogen-free Eppendorf tubes. These blood samples served as control samples for comparative analysis. All samples were stored at -80°C before tests.

DNA extraction from the collected samples was performed using the QIAamp DNA Blood Mini Kit (Qiagen, Germany) following the manufacturer’s manual. After ethanol precipitation, DNA samples were resuspended in double-distilled water and stored at -80°C until further use. All DNA extraction procedures were conducted under a class II biologic safety cabinet.

Universe primers (341F and 806R) were used for PCR amplification of the V3-V4 region of the bacterial 16S rRNA gene. PCR reactions were performed in a 20 µL mixture, which included a 10\(\times\)polymerase mix (Life Technologies, Carlsbad, CA), 10 µM concentrations of the forward and reverse primers, and 25 ng of template DNA. The amplicon sequencing libraries were prepared from the PCR products and sequenced on an Illumina HiSeq platform, generating 250-bp paired-end reads. Negative controls were included to account for potential contamination during the DNA extraction and amplification process. These controls consisted of empty sterile storage tubes that underwent the same procedures and used the same reagents as the blood samples. This helped identify and exclude any potential contaminants. Thrombi that were successfully sequenced using high-throughput sequencing methods and showed the presence of prokaryote-specific DNA was defined as Prokaryote-Specific DNA (+).

For transmission electron microscopic observation, the thrombus segments were prepared into thin sections using an ultra-microtome (UC7, Leica, Germany). These sections were then post-stained with uranyl acetate and lead citrate (Servicebio, China). The electron micrographs were taken with a Hitachi HT7800/7900 transmission electron microscope operating at 80 kV.

For immunohistochemistry, the thrombus segments were cut into 5\({\mu }\text{m}\)thick microns sections using a manual microtome (RM2016, Leica, Germany). The activity of the bacterium-specific CD14 marker was assessed using a 1:100 dilution of the SP192 clone antibody (ab183322, Abcam, Britain) applied to the thrombus sections. Following antibody incubation, diaminobenzidine (G1211, Servicebio, China) was used as a chromogen to visualize the presence of CD14.

Statistical Analysis

The raw data obtained from 16S rDNA sequencing were processed to generate operational taxonomic units (OTUs) at a 97% identity threshold using UPARSE. Taxonomy was assigned using the Ribosomal Database Project (RDP) as the reference database. The \({\alpha }\)- and \({\beta }\)-diversity indices were calculated based on the rarefied OTU counts using the Qiime program. Statistical comparisons of α-diversity indices, including the Chao1 index, observed_species index, Shannon index, and Simpson index, were conducted using the Wilcoxon rank sum test and Kruskal-Wallis test.

Quantitative variables were reported as mean ± SD or median (interquartile range) and compared with Student’s t-test or Mann–Whitney U as appropriate. Categorical variables were reported as frequency (proportion), and compared with the χ² test or Fisher exact test as appropriate. Similarities of bacterial species between thrombus and blood samples were analyzed using the R package “ade4”. Distinguishing microbial features between groups were identified using the linear discriminant analysis (LDA) effect size (LEfSe) method with an alpha cutoff of 0.05 and an effect size cutoff of 2.0. Differential abundance analysis was performed using the Kruskal-Wallis and Wilcoxon rank sum test. The association between bacteria burden and characteristics was evaluated using multivariable logistic regression. Statistical significance was defined as a P-value less than 0.05 for two-tailed tests. All statistical analyses were performed using SPSS version 22.0 (IBM, Armonk, NY).

A total of 81 patients with acute ischemic stroke were recruited, with a median age of 70 years and 52 (64.2%) of them being male. The median procedure time was 80 minutes, with an interquartile range (IQR) of 57 to 113. The median preoperative National Institute of Health Stroke Scale (NIHSS) score was 17 (IQR, 13 to 24). Among the 81 thrombus samples collected from the patients, the prokaryote-specific 16S rRNA gene was detected in 26 (32.1%) samples. More detailed patient characteristics are shown in Table 1. Further analysis revealed a diverse microbial composition, with a total of 1042 operational taxonomic units (OTUs) belonging to 296 genera, 141 families, 72 orders, 40 classes, and 21 phyla detected in these 26 thrombi. Among the identified microbes, the two most abundant bacterial phyla observed in the thrombi were Firmicutes and Bacteroidetes (Fig. 1).

Table 1

Patient Characteristics According to Prokaryote-Specific DNA in Thrombi
		Prokaryote-Specific DNA
		- n = 26	་ n = 55
Age, media (IQR)	72 (65–75)			69 (57–78)	0.46
Male gender, n (%)	20 (76.9)			32 (58.2)	0.10
BMI, media (IQR)	23.9 (21.5–25.4)			24.1 (23.2–26.1)	0.55
Hypertension	16 (61.5)			37 (67.3)	0.61
Diabetes	8 (30.8)			11 (20.0)	0.29
AF	16 (61.5)			33 (60.0)	0.62
CAD	9 (34.6)			12 (21.8)	0.22
Prior stroke	7 (26.9)			11 (20.0)	0.48
Smoking	11 (42.3)			13 (23.6)	0.09
Alcohol drinking	10 (38.5)			9 (16.4)	0.03*
Intravenous alteplase use	3 (11.5)			9 (16.4)	0.74
NIHSS score, media (IQR)	16 (11–22)			18 (14–25)	0.08
Stroke sub-type, n (%)					0.19
LAA	7 (26.9)			13 (23.6)
Cardioembolic	16 (61.5)			29 (52.8)
Others or uncertain	3 (11.6)			13 (23.6)
HDL, mmol/L, media (IQR)	1.18 (0.84–1.40)			1.11 (0.87–1.38)	0.79
LDL, mmol/L, media (IQR)	2.68 (1.44–3.06)			2.49 (2.01–2.98)	0.98
TG, mmol/L, media (IQR)	0.68 (0.53–1.06)			0.96 (0.67–1.26)	0.08
TC, mmol/L, media (IQR)	3.89 (3.21–4.87)			4.26 (3.43–4.55)	0.98
Leukocyte, ×10⁹/L, media (IQR)	10.01 (8.06–13.06)			9.39 (7.88–12.60)	0.27
CRP, mg/L, media (IQR)	3.55 (0.50-13.09)			9.9 (3.60–23.50)	0.17
Occlusion site, n (%)					0.75
ICA	9 (34.6)			19 (34.5)
MCA	15 (57.7)			28 (50.9)
Vertebrobasilar	2 (7.7)			8 (14.5)
Procedure time, media (IQR)	66 (55–95)			85 (58–120)	0.14
Thrombus fragmentation, n (%)	9 (34.6)			30 (54.5)	0.09
Successful reperfusion, n (%)	24 (92.3)			42 (76.4)	0.13
BMI, body mass index; AF, Atrial fibrillation; CAD, coronary atherosclerosis disease; NIHSS, National Institute of health stroke scale; LAA, large-artery atherosclerosis; CRP, C-reactive protein; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; TG, Triglycerides; TC, Total cholesterol; ICA, internal carotid artery; MCA, middle cerebral artery.

Microbial diversity was compared between thrombus and blood samples obtained from the same patients. No significant differences were found when analyzing the Simpson index and Shannon index, indicating similar levels of diversity between thrombus and arterial blood samples. Both the observed species index and Chao1 index were higher in thrombi compared to arterial blood. Furthermore, the observed species index and Chao1 index in thrombi were significantly higher than those observed in venous blood (Fig. 2). The higher number of OTUs in the thrombi suggested a greater relative abundance of bacteria within the thrombi compared to the blood samples. Additional analyses, such as ANOSIM (p = 0.002, Supplementary Fig. 1A) and PCoA (p = 0.001, Supplementary Fig. 1B) demonstrated significant differences in bacterial characteristics between thrombi and both arterial and venous blood samples.

LEfSe analysis revealed significant taxonomic differences in thrombus samples, highlighting specific bacterial species that were enriched in the thrombus environment. Notably, Thermaceae (LDA = 4.2, p = 0.037), Streptococcacea (LDA = 4.2, p = 0.037), Corynebacteriaceae (LDA = 3.8, p = 0.025), and Verrucomicrobiaceae (LDA = 3.4, p = 0.036) were identified as significantly bacterial taxa in thrombi (Fig. 3). In addition to taxonomic differences, the relative abundance of specific bacterial species exhibited significant variations between thrombi and arterial blood samples. Bacillus (0.04% vs 0.00046%, p = 0.003), Parabacteroides (0.20% vs 0.09%, p = 0.029), Prevotella (1.57% vs 0.38%, p = 0.010), Streptococcus (1.53% vs 0.29%, p = 0.001), Romboutsia (0.18% vs 0.0070%, p = 0.029), Corynebacterium (1.61% vs 1.26%, p = 0.026) and Roseburia (0.53% vs 0.05%, p = 0.005) exhibited higher relative abundances in thrombi compared to arterial blood (Table 2). Conversely, the relative abundance of Faecalibacterium (9.15% vs 17.07%, p = 0.008) and Escherichia/Shigella (4.09% vs 8.26%, p = 0.003) in thrombi were lower than that in arterial blood. Supplementary Table 1 provides additional information on relative abundance differences between thrombi and venous blood samples.

Table 2

Prevalence and Mean Relative Abundance of Significant Genus
Genus					p value
Streptococcus	21 (80.8)	1.53%	0.29%	5.2	0.001
Prevotella	19 (73.1)	1.57%	0.38%	4.1	0.010
Parabacteroides	13 (50.0)	0.20%	0.09%	2.4	0.029
Romboutsia	12 (46.2)	0.18%	0.0070%	26.2	0.029
Roseburia	16 (61.5)	0.53%	0.05%	9.7	0.005
Bacillus	8 (30.8)	0.04%	0.00046%	86.7	0.003
Corynebacterium	22 (84.6)	1.60%	1.26%	1.3	0.026
Escherichia/Shigella	25 (96.2)	4.09%	8.26%	0.5	0.003
Faecalibacterium	24 (92.3)	9.14%	17.07%	0.5	0.008

Partial bacteria-like structures were observed in 22 (27.1%) thrombi samples and whole bacteria-like structures were observed in 7 (8.6%) thrombi samples. These observations were made using transmission electron microscopy (Fig. 4). Immunohistochemical staining targeting CD14, a bacterium-specific monocyte/macrophage marker, revealed positive staining in 63.0% of the 81 thrombi samples examined. Figure 5 visually represents the immunohistochemical staining results for CD14 in the thrombi.

The logistic regression analysis revealed a significant association between the presence of prokaryote-specific DNA (+) and alcohol consumption among the patients. 38.5% of the prokaryote-specific DNA (+) patients were found to be alcohol drinkers, compared to 16.4% among those without prokaryote-specific DNA. This difference in alcohol consumption between the two groups was statistically significant (p = 0.03). After adjusting for age and sex, multivariable logistic regression analysis indicated that current alcohol drinking was significantly associated with a higher bacteria burden in thrombi (odds ratio = 3.19; 95% CI, 1.10–9.27; p = 0.033).

This study analyzed the microbiome in thrombi, arterial blood, and venous blood samples obtained from patients with acute ischemic stroke. The results revealed that several bacterial taxa, including Bacillus, Corynebacterium, Parabacteroides, Romboutsia, Roseburia, Prevotella, and Streptococcus, exhibited a higher relative abundance in thrombi compared to arterial blood samples. Our findings may suggest a distinct microbial profile within the thrombus compared to the circulating arterial blood.

A wide range of infectious agents have been associated with the development of atherosclerosis (16, 17). Streptococcus mitis, commonly found in the oral cavity, can enter blood flow, adhere to vascular endothelium, induce platelet aggregation, and then form a biofilm that may serve as attachment points for other bacteria (18). Periodontitis, caused by Gram-negative bacteria, can lead to persistent endotoxemia (19, 20). It is worth noting that endotoxemia is quite common after periodontal examination, tooth extractions, and even tooth brushing (21, 22). The gut, which has the greatest variety and number of bacteria in the human body (23), is considered a significant source of endotoxins (24). Bacteria can enter the bloodstream and reach atherosclerotic plaques through compromised intestinal epithelial membranes or macrophage phagocytosis (25). Studies have demonstrated the presence of oral and gut bacteria in valvular vegetation, endocardium, and atherosclerotic plaques (8, 13, 26). These findings indicate the potential involvement of both oral and gut bacteria in the pathogenesis of atherosclerosis.

Accumulating evidence suggests that bacterial infection can accelerate the rupture of atherosclerotic plaque (9, 27). The debris resulting from these plaque ruptures can then obstruct downstream arteries, potentially leading to cerebral infarction. When a plaque ruptures, the microorganisms contained within it can enter the in-situ thrombus (12). Additionally, specific species such as Bacillus cereus and Bacillus anthracis have been found to have the ability to directly initiate blood coagulation and enter the thrombus (28). These mechanisms further emphasize the potential role of bacterial infections in promoting thrombus formation and its subsequent complications.

Left atrial remodeling plays a significant role in the development of atrial fibrillation (AF) and stroke. One of the key features of left atrial remodeling is the dilation and dysfunction of the left atrium, which can result in blood stasis within the atrial chambers (29). This stagnant blood flow provides an ideal milieu for bacteria to aggregate and potentially initiate infections. Bacterial interactions with platelet receptors are of particular importance in the context of thrombosis. Bacteria or bacterial-derived factors, such as lipopolysaccharide, can bind to platelet receptors, leading to platelet activation. This activation can further trigger neutrophil engagement and the release of neutrophil extracellular traps, all of which contribute to the promotion of blood coagulation (30). Moreover, bacterial DNA has been shown to have heparin-like properties. This bacterial DNA can form antigenic complexes similar to those formed with heparin, resulting in comparable levels of platelet aggregation and thrombosis (31). This highlights the potential role of bacterial DNA in promoting thrombotic events.

This study established an association between alcohol consumption and the bacterial burden observed in cerebral artery thrombi. Previous research has linked alcohol drinking to the advancement of atherosclerosis (32). Long-term alcohol consumption has been shown to alter the composition of the intestinal microbiota and compromise the integrity of the intestinal mucosal barrier (33). Consequently, the increased intestinal permeability may facilitate the entry of pathogens into the bloodstream (34, 35). Heavy alcohol consumption has been specifically associated with an elevated cardiovascular risk within the subsequent day (36). These findings suggest that the detrimental effects of alcohol consumption on the intestinal microbiota and mucosal barrier may contribute to an increased bacterial burden in cerebral artery thrombi.

Our study acknowledged a major limitation regarding the 16S rRNA gene sequencing method employed, which only allowed for the detection of bacterial DNA within the samples but not the live microorganisms or their metabolic activity. The small size of the samples hindered the quantification of bacterial DNA concentration within the thrombi. Additionally, there is a possibility that the observed excessive relative abundance of certain genera within the thrombi could be attributed to phagocytized bacterial components derived from biofilms. These limitations underscore the need for future studies to explore the functional aspects of bacterial involvement in thrombogenesis, beyond mere DNA detection, and to investigate the specific roles played by bacterial components in the process.

The detection of bacterial signatures typically found in the oral cavity and digestive tract within thrombi from patients with ischemic stroke suggests a potential role for bacterial infection in thrombogenesis and an increased risk of ischemic stroke. This finding supports the idea that bacteria present in these regions may contribute to the development of thrombi and subsequent stroke. Moreover, long-term alcohol consumption has been associated with an increased risk of ischemic stroke. This suggests that alcohol drinking may further enhance the risk of bacterial infection-associated thrombogenesis and ischemic stroke. These observations highlight the potential interplay between bacterial infection, thrombogenesis, and the increased risk of ischemic stroke. Further research is needed to better understand the underlying mechanisms and develop effective preventive measures and treatments.

Acknowledgment

The study was partly supported by the National Natural Science Foundation of China (No. 82171330).

The authors thank Sijiao Hu and Yan Zhang for their help in the sample collection.

X.W. and G.X. conceived the study, sought funding support, and conducted the experiments. X.W. and Y.C. performed the pathological experiments and collected the samples. J.G. performed microbiota analyses and drafted the manuscript. X.Z., Q.D., and L.X. performed the endovascular recanalization treatment and provided the thrombus samples. M.P., X.J., T.M., and X.L. collected the clinical data. X.W., Z.D., and H.C. critically revised the manuscript. All authors contributed to the article and approved the submitted version.

We have no conflict of interest to declare.

Ethical Approval

The Ethic Review Board of Jinling Hospital approved the study protocol, ensuring adherence to the principles and guidelines set forth in the Declaration of Helsinki.

All participants provided informed consent before enrollment.

Competing interests

All authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and/or discussion reported in this paper.

Authors' contributions

Xiaoke Wang and Jie Gao wrote the main manuscript text. Yantong Chen and Xiaohao Zhang contributed to the acquisition and analysis of data. Zhengze Dai and Qiliang Dai were responsible for the interpretation of data. Mengna Peng and Lulu Xiao contributed to the sample handling. Xuerong JIa, Haodi Cai, and Xiang Li contributed to the collection of samples. Gelin Xu substantively revised it. All authors reviewed the manuscript.

Funding

The study was partly supported by the National Natural Science Foundation of China (No. 82171330).

Availability of data and materials

The dataset analyzed during our study is available upon reasonable request to the corresponding author, subject to obtaining the appropriate approvals.

Rosenfeld ME. Inflammation and atherosclerosis: direct versus indirect mechanisms. Curr Opin Pharmacol. 2013;13:154–60.
Palm F, Pussinen PJ, Aigner A, Becher H, Buggle F, Bauer MF, Grond-Ginsbach C, Safer A, Urbanek C, Grau AJ. Association between infectious burden, socioeconomic status, and ischemic stroke. Atherosclerosis. 2016;254:117–23.
Jackel S, Kiouptsi K, Lillich M, Hendrikx T, Khandagale A, Kollar B, Hormann N, Reiss C, Subramaniam S, Wilms E, Ebner K, Bruhl MV, Rausch P, Baines JF, Haberichter S, Lammle B, Binder CJ, Jurk K, Ruggeri ZM, Massberg S, Walter U, Ruf W, Reinhardt C. Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2. Blood. 2017;130:542–53.
Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. 2020. Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients 12.
Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038.
Lafon A, Pereira B, Dufour T, Rigouby V, Giroud M, Bejot Y, Tubert-Jeannin S. Periodontal disease and stroke: a meta-analysis of cohort studies. Eur J Neurol. 2014;21:1155–61. e66-7.
Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large populati on study. Circulation. 2001;103:1064–70.
Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, Backhed F. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4592–8.
Mitra S, Drautz-Moses DI, Alhede M, Maw MT, Liu Y, Purbojati RW, Yap ZH, Kushwaha KK, Gheorghe AG, Bjarnsholt T, Hansen GM, Sillesen HH, Hougen HP, Hansen PR, Yang L, Tolker-Nielsen T, Schuster SC, Givskov M. 2015. In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome 3:38.
Ohki T, Itabashi Y, Kohno T, Yoshizawa A, Nishikubo S, Watanabe S, Yamane G, Ishihara K. Detection of periodontal bacteria in thrombi of patients with acute myocardial infarction by polymerase chain reaction. Am Heart J. 2012;163:164–7.
Pessi T, Karhunen V, Karjalainen PP, Ylitalo A, Airaksinen JK, Niemi M, Pietila M, Lounatmaa K, Haapaniemi T, Lehtimaki T, Laaksonen R, Karhunen PJ, Mikkelsson J. Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation. 2013;127:1219–28. e1-6.
Vakhitov D, Tuomisto S, Martiskainen M, Korhonen J, Pessi T, Salenius JP, Suominen V, Lehtimaki T, Karhunen PJ, Oksala N. Bacterial signatures in thrombus aspirates of patients with lower limb arterial and venous thrombosis. J Vasc Surg. 2018;67:1902–7.
Oliveira FAF, Forte CPF, Silva PGB, Lopes CB, Montenegro RC, Santos A, Sobrinho C, Mota MRL, Sousa FB, Alves A. 2015. Molecular Analysis of Oral Bacteria in Heart Valve of Patients With Cardiovascular Disease by Real-Time Polymerase Chain Reaction. Med (Baltim) 94e2067.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.
Fugate JE, Klunder AM, Kallmes DF. What Is Meant by "TICI"? Am J Neuroradiol. 2013;34:1792–7.
Levi M, van der Poll T, Schultz M. Infection and inflammation as risk factors for thrombosis and atherosclerosis. Semin Thromb Hemost. 2012;38:506–14.
Choi H, Dey AK, Priyamvara A, Aksentijevich M, Bandyopadhyay D, Dey D, Dani S, Guha A, Nambiar P, Nasir K, Jneid H, Mehta NN, Lavie CJ, Amar S. Role of Periodontal Infection, Inflammation and Immunity in Atherosclerosis. Curr Probl Cardiol. 2021;46:100638.
Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol. 2010;8:471–80.
Geerts SO, Nys M, De MP, Charpentier J, Albert A, Legrand V, Rompen EH. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol. 2002;73:73–8.
Pussinen PJ, Vilkuna-Rautiainen T, Alfthan G, Palosuo T, Jauhiainen M, Sundvall J, Vesanen M, Mattila K, Asikainen S. Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2004;24:2174–80.
Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117:3118–25.
Olsen I. Update on bacteraemia related to dental procedures. Transfus Apher Sci. 2008;39:173–8.
Sears CL. A dynamic partnership: celebrating our gut flora. Anaerobe. 2005;11:247–51.
Koopen AM, Groen AK, Nieuwdorp M. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk. Curr Opin Lipidol. 2016;27:615–22.
Castillo DJ, Rifkin RF, Cowan DA, Potgieter M. The Healthy Human Blood Microbiome: Fact or Fiction? Front Cell Infect Microbiol. 2019;9:148.
Oberbach A, Schlichting N, Friedrich M, Lehmann S, Kullnick Y, Pichlmaier M, Hagl C, Bagaev E. CardiOmics g, Clinical Microbiology g, Clinical Management g. 2020. Quantification of Multiple Bacteria in Calcified Structural Valvular Heart Disease. Semin Thorac Cardiovasc Surg 32:255–63.
Lanter BB, Sauer K, Davies DG. Bacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture. mBio. 2014;5:e01206–14.
Kastrup CJ, Boedicker JQ, Pomerantsev AP, Moayeri M, Bian Y, Pompano RR, Kline TR, Sylvestre P, Shen F, Leppla SH, Tang WJ, Ismagilov RF. Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'. Nat Chem Biol. 2008;4:742–50.
Delgado V, Di Biase L, Leung M, Romero J, Tops LF, Casadei B, Marrouche N, Bax JJ. Structure and Function of the Left Atrium and Left Atrial Appendage: AF and Stroke Implications. J Am Coll Cardiol. 2017;70:3157–72.
Arthur J, Andrews R, Gardiner E. Neutrophil extracellular traps (NETs) and the role of platelets in infection. Thromb Haemost. 2017;112:659–65.
Krauel K, Weber C, Brandt S, Zahringer U, Mamat U, Greinacher A, Hammerschmidt S. Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes. Blood. 2012;120:3345–52.
Noflatscher M, Schreinlechner M, Sommer P, Deutinger P, Theurl M, Kirchmair R, Bauer A, Marschang P. 2020. Association of Food and Alcohol Consumption with Peripheral Atherosclerotic Plaque Volume as Measured by 3D-Ultrasound. Nutrients 12.
Bishehsari F, Magno E, Swanson G, Desai V, Voigt RM, Forsyth CB, Keshavarzian A. Alcohol and Gut-Derived Inflammation. Alcohol Res. 2017;38:163–71.
Leclercq S, Cani PD, Neyrinck AM, St?rkel P, Jamar F, Mikolajczak M, Delzenne NM, de Timary P. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol- dependent subjects. Brain Behav Immun. 2012;26:911–8.
Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y, Gobejishvili L, Joshi-Barve S, Ayvaz T, Petrosino J, Kong M, Barker D, McClain C, Barve S. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the e ffect of Lactobacillus rhamnosus GG treatment. PLoS ONE. 2013;8:e53028.
Mostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA. Alcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analy sis. Circulation. 2016;133:979–87.

No competing interests reported.

Supplementarymaterial.docx

Download PDF

Journal Publication

published 23 Jan, 2024

Read the published version in Thrombosis Journal →

Editorial decision: Revision requested
29 Nov, 2023
Reviews received at journal
29 Nov, 2023
Reviews received at journal
23 Oct, 2023
Reviewers agreed at journal
10 Oct, 2023
Reviewers agreed at journal
07 Sep, 2023
Reviewers invited by journal
30 Aug, 2023
Editor assigned by journal
07 Aug, 2023
Submission checks completed at journal
07 Aug, 2023
First submitted to journal
30 Jul, 2023

You are reading this latest preprint version

Detecting Prokaryote-Specific Gene and Other Bacterial Signatures in Thrombi from Patients with Acute Ischemic Stroke

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Materials and Methods

Patients

Stroke Evaluation and Endovascular Treatment

Detection of Bacterial Signatures

Statistical Analysis

Results

Discussion

Declarations

References

Additional Declarations

Supplementary Files

Status:

Journal Publication

Version 1